Article Details
Retrieved on: 2019-03-02 03:35:26
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div>Capital Fund Management Sa decreased its stake in Abbott Laboratories (ABT) by 64.24% based on its latest 2018Q3 regulatory filing with the SEC.</div>
Article found on:
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here